Back to search

Article

Point-of-care serological assays for SARS-CoV-2 in a UK hospital population: potential for enhanced case finding

2020-05-09

Abstract excerpt

<title>Abstract</title> <p>Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) has become a global pandemic. Case identification is currently made by real-time polymerase chain reaction (PCR) during the acute phase and largely restricted to healthcare laboratories. Serological assays are emerging but independent validation is urgently required to assess their utility.We evaluated five different point-of-...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cedb6d2c-bbd2-5174-b642-c01d605daa35
DOI
10.21203/rs.3.rs-28006/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Point-of-care serological assays for SARS-CoV-2 in a UK hospital population: potential for enhanced case findingDOI 10.21203/rs.3.rs-28006/v1
Accuracy of Rapid Point-of-Care Antibody Test in patients with suspected or confirmed COVID-19Semantic proximity
Clinical utility of targeted SARS-CoV-2 serology testing to aid the diagnosis and management of suspected missed, late or post-COVID-19 infection syndromes: results from a pilot serviceSemantic proximity
Analytical Performances of the Point-of-Care BIOSYNEX COVID-19 Ag BSS for the Detection of SARS‐CoV‐2 Nucleocapsid Protein in Nasopharyngeal Swabs: A Prospective Field Evaluation During the COVID-19 Third Wave in FranceSemantic proximity
Evaluating ten commercially-available SARS-CoV-2 rapid serological tests using the STARD (Standards for Reporting of Diagnostic Accuracy Studies) methodSemantic proximity
Screening for SARS-CoV-2 in close contacts of individuals with confirmed infection: performance and operational considerationsSemantic proximity
Evaluation of SARS-CoV-2 Antibody Point of Care Devices in the Laboratory and Clinical SettingSemantic proximity
Analytical Performance of the Point-of-care BIOSYNEX COVID-19 Ag BSS for the Detection of SARS‐CoV‐2 Nucleocapsid Protein in Nasopharyngeal Swabs: A Prospective Field Evaluation During the COVID-19 Third Wave in FranceSemantic proximity
Clinical Assessment of the Roche SARS-CoV-2 Rapid Antigen TestSemantic proximity
Diagnostic accuracy of three prevailing rapid antigen tests for detection of SARS-CoV-2 infection in the general population: cross sectional studySemantic proximity
Diagnostic accuracy of six commercial SARS-CoV-2 IgG/total antibody assays and identification of SARS-CoV-2 neutralizing antibodies in convalescent seraSemantic proximity
Diagnostic accuracy of two commercially available rapid assays for detection of IgG and IgM antibodies to SARS-CoV-2 compared to ELISA in a low-prevalence populationSemantic proximity
Analytical evaluation and critical appraisal of early commercial SARS-CoV-2 immunoassays for routine use in a diagnostic laboratorySemantic proximity
Select a neighboring publication to make it the new centre.